Literature DB >> 35029771

Combining subjective and objective appraisals of cognitive dysfunction in patients with cancer: a deeper understanding of meaning and impact on suffering?

Hanne Bess Boelsbjerg1,2, Geana Paula Kurita3,4,5, Per Sjøgren6,7, Niels Viggo Hansen8.   

Abstract

PURPOSE: Patients with advanced cancer often experience cognitive dysfunction, which may influence decision making, self-perception, and existential well-being. However, there is little evidence regarding this issue. This study analysed associations between objective neuropsychological measures and patients' self-report of cognitive dysfunction interfering with everyday life, general well-being, and sense of existential value.
METHODS: A mixed method study assessed 13 adult patients with advanced cancer with validated neuropsychological tests, which assessed sustained attention, psychomotor speed, memory/attention, mental flexibility, and a measure of global cognitive function. These were followed by semi-structured interviews focusing on subjective experiences of cognitive dysfunction. Agreement between subjective and objective measures were analysed by Cohen's Kappa (k). Thematic analysis explored associations with cognitive deficits.
RESULTS: Poor cognitive performance on the neuropsychological tests was observed regarding sustained attention (n = 8), psychomotor speed (n = 1), memory/attention (n = 2), mental flexibility (n = 9), and global cognitive function (n = 3). Almost all patients (n = 12) had complaints of cognitive dysfunction. However, the agreement between the two assessments was weak (k ≤ 0.264). Cognitive dysfunction challenged the patients with regard to practice everyday life including their existential values related to meaning of life and well-being. Adjustment of the sense of living according to one's existential values and changes of self-perception were also related positively and negatively to existential well-being.
CONCLUSION: Despite the weak agreement between objective and subjective measures of cognitive function, many of the patients reported experiences of cognitive dysfunction that had an impact on their daily life and existential well-being, adding to the suffering experienced.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Cognitive dysfunction; Existential well-being; Neoplasms; Neuropsychological tests; Patient-reported outcome measures; Qualitative research

Mesh:

Year:  2022        PMID: 35029771     DOI: 10.1007/s00520-021-06777-7

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  25 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Objective-subjective disparity in cancer-related cognitive impairment: does the use of change measures help reconcile the difference?

Authors:  Erin O'Farrell; Andra Smith; Barbara Collins
Journal:  Psychooncology       Date:  2016-07-14       Impact factor: 3.894

3.  Prolonged practice of a simple motor task by preferred and nonpreffered hands.

Authors:  M Peters
Journal:  Percept Mot Skills       Date:  1976-10

Review 4.  An update on cancer- and chemotherapy-related cognitive dysfunction: current status.

Authors:  Michelle C Janelsins; Sadhna Kohli; Supriya G Mohile; Kenneth Usuki; Tim A Ahles; Gary R Morrow
Journal:  Semin Oncol       Date:  2011-06       Impact factor: 4.929

5.  Assessment of cognitive function in patients with metastatic cancer: Are we using the right tools?

Authors:  Geana Paula Kurita; Marlene Sandvad; Lena Lundorff; Cibele Andrucioli De Mattos-Pimenta; Jette Højsted; Per Sjøgren
Journal:  Palliat Support Care       Date:  2017-08-07

Review 6.  Continuous reaction times in cerebral dysfunction.

Authors:  P Elsass
Journal:  Acta Neurol Scand       Date:  1986-03       Impact factor: 3.209

7.  Cognitive Impairment and Pain Among Nursing Home Residents With Cancer.

Authors:  Catherine E Dubé; Deborah S Mack; Jacob N Hunnicutt; Kate L Lapane
Journal:  J Pain Symptom Manage       Date:  2018-02-26       Impact factor: 3.612

Review 8.  Broadening the cancer and cognition landscape: the role of self-regulatory challenges.

Authors:  Jamie Arndt; Enny Das; Sanne B Schagen; Stephanie A Reid-Arndt; Linda D Cameron; Tim A Ahles
Journal:  Psychooncology       Date:  2013-07-10       Impact factor: 3.894

Review 9.  The panorama of opioid-related cognitive dysfunction in patients with cancer: a critical literature appraisal.

Authors:  Peter G Lawlor
Journal:  Cancer       Date:  2002-03-15       Impact factor: 6.860

Review 10.  Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults.

Authors:  Jeffrey S Wefel; Shelli R Kesler; Kyle R Noll; Sanne B Schagen
Journal:  CA Cancer J Clin       Date:  2014-12-05       Impact factor: 508.702

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.